Cargando…
Inhibition of lncRNA KCNQ1OT1 Improves Apoptosis and Chemotherapy Drug Response in Small Cell Lung Cancer by TGF-β1 Mediated Epithelial-to-Mesenchymal Transition
PURPOSE: Drug resistance is one of the main causes of chemotherapy failure in patients with small cell lung cancer (SCLC), and extensive biological studies into chemotherapy drug resistance are required. MATERIALS AND METHODS: In this study, we performed lncRNA microarray, in vitro functional assays...
Autores principales: | Li, Deyu, Tong, Qin, Lian, Yuane, Chen, Zhizhong, Zhu, Yaru, Huang, Weimei, Wen, Yang, Wang, Qiongyao, Liang, Shumei, Li, Man, Zheng, Jianjing, Liu, Zhenhua, Liu, Huanxin, Guo, Linlang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Cancer Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524015/ https://www.ncbi.nlm.nih.gov/pubmed/33705625 http://dx.doi.org/10.4143/crt.2020.1208 |
Ejemplares similares
-
KCNQ1OT1 lncRNA affects the proliferation, apoptosis, and chemoresistance of small cell lung cancer cells via the JAK2/STAT3 axis
por: Zhu, Yaru, et al.
Publicado: (2021) -
Regulation of functional KCNQ1OT1 lncRNA by β-catenin
por: Sunamura, Naohiro, et al.
Publicado: (2016) -
LncRNA KCNQ1OT1: Molecular mechanisms and pathogenic roles in human diseases
por: Xia, Fangqi, et al.
Publicado: (2021) -
LncRNA KCNQ1OT1 predicts further cerebral events in patients with transient ischemic attack
por: Yu, Shijia, et al.
Publicado: (2022) -
LncRNA KCNQ1OT1 promotes osteogenic differentiation to relieve osteolysis via Wnt/β-catenin activation
por: Gao, Xuren, et al.
Publicado: (2018)